Sulfasalazine: My study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-05-28 12:04 (755 d 08:55 ago) – Posting: # 20304
Views: 2,226

Hi Irene,

» Have anyone here ever conducted Bioequivalence study of Sulfasalazine?

Yes. My results (T1: 1×4 500 mg IR, T2: 1×4 500 mg enteric coated, R: 2,000 mg suspension, six-sequence Williams’ design, sampling for 60 hours, washout two weeks, 24 eligible subjects, plasma and urine). This study was performed for the originator. Both test products showed lower bioavailabilities of sulfasalazine and 5-ASA, whereas sulfapyridine and N-acetylsulfapyridine were BE. CVs for plasma:Given the high variabilities of Sulfasalazine and 5-ASA I suggest reference-scaling.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,530 posts in 4,499 threads, 1,524 registered users;
online 9 (0 registered, 9 guests [including 2 identified bots]).
Forum time: Monday 20:59 CEST (Europe/Vienna)

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5